New research indicates that people who come off new slimming jabs like semaglutide or tirzepatide may regain reduced body mass at a significantly accelerated pace than those who halt traditional diet and exercise regimens.
Published data in a prominent health publication demonstrates that while obese people can lose a large proportion of their body weight while undergoing treatment, the weight is regained at an average rate of 0.8 kg per month once they quit.
"People purchasing these treatments need to be informed of the potential of quick weight regain when the treatment concludes," cautioned lead investigator Dr. Susan Jebb.
This pace of recovery implies a return to original mass in about 18 months.
Weighing Therapies
The analysis, which reviewed 37 of studies involving over 9,000 of patients, compared the effects of the injectable medications with other pills.
Scientists emphasize that people who lose weight through diet and exercise usually experience a slower creep back—perhaps 0.1 kg a month—after stopping.
Explaining the Quick Rebound
Nutrition scientists suggest the mode of action of the jabs explains the amplified weight return.
The injections mimic a natural hormone called GLP-1, which moderates feelings of fullness.
"Sustained high doses of the hormone concentrations several times higher than normal could lead to the body to generate a reduced amount of its endogenous GLP-1, and could lessen responsiveness to its effects," explained Dr. Adam Collins, a nutrition specialist.
"Stopping of this hormone supplement means hunger is no longer kept in check, making binge eating a significant risk."
An Ongoing Condition?
The NHS suggest the injections for individuals with weight-linked medical conditions, accompanied by prescribed diet and exercise modifications.
A number of clinicians argue that, due to the likelihood of weight regain, the treatment should be considered ongoing.
This opinion is supported by drug manufacturers, who note that the results "highlight the long-term character of excess weight," comparing it to managing conditions like hypertension.
User Accounts
People who have stopped the jabs report a sudden return of cravings.
"It felt as if a switch that goes on and I was suddenly extremely hungry," described an individual.
The struggle is exacerbated if users have not adopted permanent dietary or behavioural modifications during treatment.
Widespread Interest
Figures indicate that millions of adults in the UK have tried these injections in the last 12 months, with interest remaining high.
- Use is more common among women than males.
- The 40s and 50s age group shows the highest level of interest.
- Many access the drugs through private prescriptions rather than public health services.
Ultimately, experts emphasize that while these medications are potent agents for shedding pounds, they are not a standalone cure and lasting health benefits hinges on combined lifestyle management.
